vs
EMPIRE PETROLEUM CORP（EP）与Profound Medical Corp.（PROF）财务数据对比。点击上方公司名可切换其他公司
EMPIRE PETROLEUM CORP的季度营收约是Profound Medical Corp.的1.2倍（$7.1M vs $6.0M），Profound Medical Corp.净利率更高（-136.8% vs -835.1%，领先698.4%）
伊拉克石油公司，前身为土耳其石油公司，是一家石油企业，1925年至1961年间几乎垄断了伊拉克境内所有石油勘探与开采业务，由当时全球多家顶尖石油企业共同持股，公司总部设立于英国伦敦。
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
EP vs PROF — 直观对比
营收规模更大
EP
是对方的1.2倍
$6.0M
净利率更高
PROF
高出698.4%
-835.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.1M | $6.0M |
| 净利润 | $-59.0M | $-8.2M |
| 毛利率 | — | 66.8% |
| 营业利润率 | -834.5% | -123.3% |
| 净利率 | -835.1% | -136.8% |
| 营收同比 | -30.0% | — |
| 净利润同比 | -1306.0% | — |
| 每股收益（稀释后） | $-1.74 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EPPROF
| Q4 25 | $7.1M | $6.0M | ||
| Q3 25 | $9.4M | $5.1M | ||
| Q2 25 | $8.8M | $2.0M | ||
| Q1 25 | $9.0M | $2.3M | ||
| Q4 24 | $10.1M | — | ||
| Q3 24 | $11.4M | — | ||
| Q2 24 | $12.8M | — | ||
| Q1 24 | $9.4M | — |
净利润EPPROF
| Q4 25 | $-59.0M | $-8.2M | ||
| Q3 25 | $-3.8M | $-8.0M | ||
| Q2 25 | $-5.1M | $-15.7M | ||
| Q1 25 | $-4.2M | $-10.7M | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-3.6M | — | ||
| Q2 24 | $-4.4M | — | ||
| Q1 24 | $-4.0M | — |
毛利率EPPROF
| Q4 25 | — | 66.8% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 81.7% | ||
| Q1 25 | — | 79.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率EPPROF
| Q4 25 | -834.5% | -123.3% | ||
| Q3 25 | -37.8% | -176.2% | ||
| Q2 25 | -56.0% | -696.9% | ||
| Q1 25 | -43.9% | -477.0% | ||
| Q4 24 | -38.9% | — | ||
| Q3 24 | -30.0% | — | ||
| Q2 24 | -15.0% | — | ||
| Q1 24 | -46.8% | — |
净利率EPPROF
| Q4 25 | -835.1% | -136.8% | ||
| Q3 25 | -40.9% | -157.7% | ||
| Q2 25 | -57.8% | -792.3% | ||
| Q1 25 | -46.9% | -458.1% | ||
| Q4 24 | -41.6% | — | ||
| Q3 24 | -32.0% | — | ||
| Q2 24 | -34.3% | — | ||
| Q1 24 | -42.3% | — |
每股收益（稀释后）EPPROF
| Q4 25 | $-1.74 | $0.27 | ||
| Q3 25 | $-0.11 | $0.26 | ||
| Q2 25 | $-0.15 | $0.52 | ||
| Q1 25 | $-0.12 | $0.36 | ||
| Q4 24 | $-0.12 | — | ||
| Q3 24 | $-0.12 | — | ||
| Q2 24 | $-0.15 | — | ||
| Q1 24 | $-0.15 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2M | $59.7M |
| 总债务越低越好 | — | $4.5M |
| 股东权益账面价值 | $-4.6M | $66.4M |
| 总资产 | $65.9M | $77.5M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资EPPROF
| Q4 25 | $1.2M | $59.7M | ||
| Q3 25 | $4.6M | $24.8M | ||
| Q2 25 | $2.3M | $35.2M | ||
| Q1 25 | $1.1M | $46.4M | ||
| Q4 24 | $2.3M | — | ||
| Q3 24 | $3.1M | — | ||
| Q2 24 | $9.3M | — | ||
| Q1 24 | $3.5M | — |
总债务EPPROF
| Q4 25 | — | $4.5M | ||
| Q3 25 | $15.2M | $4.5M | ||
| Q2 25 | $14.6M | $4.5M | ||
| Q1 25 | $11.6M | $4.5M | ||
| Q4 24 | $11.3M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.5M | — |
股东权益EPPROF
| Q4 25 | $-4.6M | $66.4M | ||
| Q3 25 | $53.7M | $32.1M | ||
| Q2 25 | $54.5M | $39.3M | ||
| Q1 25 | $59.1M | $50.8M | ||
| Q4 24 | $62.8M | — | ||
| Q3 24 | $56.5M | — | ||
| Q2 24 | $58.7M | — | ||
| Q1 24 | $31.7M | — |
总资产EPPROF
| Q4 25 | $65.9M | $77.5M | ||
| Q3 25 | $123.0M | $42.3M | ||
| Q2 25 | $124.7M | $49.7M | ||
| Q1 25 | $123.7M | $60.9M | ||
| Q4 24 | $123.9M | — | ||
| Q3 24 | $121.2M | — | ||
| Q2 24 | $119.9M | — | ||
| Q1 24 | $100.1M | — |
负债/权益比EPPROF
| Q4 25 | — | 0.07× | ||
| Q3 25 | 0.28× | 0.14× | ||
| Q2 25 | 0.27× | 0.11× | ||
| Q1 25 | 0.20× | 0.09× | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.8M | $-6.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流EPPROF
| Q4 25 | $-2.8M | $-6.6M | ||
| Q3 25 | $330.0K | $-9.6M | ||
| Q2 25 | $-3.1M | $-13.7M | ||
| Q1 25 | $1.6M | $-8.3M | ||
| Q4 24 | $-8.8M | — | ||
| Q3 24 | $12.8M | — | ||
| Q2 24 | $-1.8M | — | ||
| Q1 24 | $3.9M | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
